Here, we describe the successful treatment of three patients with convalescent donor plasma (CP) who developed severe COVID-19 directly after receiving KTx. Abbreviations AKI acute kidney injury anti-ATIIR1 anti-angiotensin2 -receptor-1 antibody anti-ETA anti-endothelin antibody CP convalescent donor plasma DBD donation after brain death DSA donor-specific HLA-antibodies ESP European Senior Programme ICU intensive care unit IS Immunosuppression KTx kidney transplantation LD living donation MPA mycophenolic acid TAC tacrolimus Currently, there are no established treatment protocols for COVID-19 that is immediately acquired after kidney transplantation (KTx). Convalescent plasma treatment for early post-kidney transplant acquired COVID-19. [Extracted from the article]